APC and neoplasm: Significantly increased LOH in our tumours with just 1 somatic APC mutation, the trans position of 2 pathogenic APC mutations confirmed in tumours where the mutation phase was tested, and preferential loss of the wildtype allele in tumours with LOH and an APC mutation support the two-hit model.